Bharat Biotech’s Covaxin has 77.8% efficacy rate, presents no safety concerns
Bharat Biotech’s indigenous Covid-19 vaccine is highly efficacious, well tolerated and presents no safety concerns, a new study published in the reputed medical journal The Lancet has said.
Bharat Biotech's Covaxin found to have a 77.8%…